April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Caterina Sposetti: The impact of a weight loss intervention on key metabolic biomarkers in the phase III BWEL study
Dec 17, 2024, 23:14

Caterina Sposetti: The impact of a weight loss intervention on key metabolic biomarkers in the phase III BWEL study

Caterina Sposetti, Medical Oncology Fellow at Dana-Farber’s Breast Oncology Center and Dana-Farber Zakim Center, posted on X:

Dr. Ligibel summarizes the significant impact of a weight loss intervention on key metabolic biomarkers, i.e. leptin, insulin, CRP, insulin resistance (HOMA) in the phase III BWEL study (n=3,181), elegantly presented at SABCS 2024.”

Caterina Sposetti: The impact of a weight loss intervention on key metabolic biomarkers in the phase III BWEL study